Targeted Therapy Leads 2012 Cancer Advances
(MedPage Today) — Targeted therapies for metastatic HER2-positive breast cancer are among this year’s top advances in oncology, according to the American Society of Clinical Oncology.
(MedPage Today) — Targeted therapies for metastatic HER2-positive breast cancer are among this year’s top advances in oncology, according to the American Society of Clinical Oncology.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information: verify here.